Authors:
ROTHENBERG ML
MOORE MJ
CRIPPS MC
ANDERSEN JS
PORTENOY RK
BURRIS HA
GREEN MR
TARASSOFF PG
BROWN TD
CASPER ES
STORNIOLO AM
VONHOFF DD
ALBERTS DS
WOLFF R
KELSEN DP
KOCHA W
HALLER DG
MODIANOREVAH M
MOORE M
OKEN MM
SCHILSKY RL
SHAH A
Citation: Ml. Rothenberg et al., A PHASE-II TRIAL OF GEMCITABINE IN PATIENTS WITH 5-FU-REFRACTORY PANCREAS CANCER, Annals of oncology, 7(4), 1996, pp. 347-353
Authors:
OROURKE TJ
BROWN TD
HAVLIN K
KUHN JG
CRAIG JB
BURRIS HA
SATTERLEE WG
TARASSOFF PG
VONHOFF DD
Citation: Tj. Orourke et al., PHASE-I CLINICAL-TRIAL OF GEMCITABINE GIVEN AS AN INTRAVENOUS BOLUS ON 5 CONSECUTIVE DAYS, European journal of cancer, 30A(3), 1994, pp. 417-419
Authors:
CASPER ES
GREEN MR
KELSEN DP
HEELAN RT
BROWN TD
FLOMBAUM CD
TROCHANOWSKI B
TARASSOFF PG
Citation: Es. Casper et al., PHASE-II TRIAL OF GEMCITABINE (2,2'-DIFLUORODEOXYCYTIDINE) IN PATIENTS WITH ADENOCARCINOMA OF THE PANCREAS, Investigational new drugs, 12(1), 1994, pp. 29-34